A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors
2021
PLoS ONE
Timely and accurate identification of molecular alterations in solid tumors is essential for proper management of patients with advanced cancers. This has created a need for rapid, scalable comprehensive genomic profiling (CGP) systems that detect an increasing number of therapeutically-relevant variant types and molecular signatures. In this study, we assessed the analytical performance of the TruSight Oncology 500 High-Throughput assay for detection of somatic alterations from formalin-fixed
doi:10.1371/journal.pone.0260089
pmid:34855780
pmcid:PMC8639101
fatcat:p5zjaxnhs5grnma4s5s4jxeuii